Edinburgh Research Explorer

Prof John Smyth

(Former employee or visitor)

  1. 2005
  2. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen

    O'Donnell, A. J. M., Macleod, K. G., Burns, D. J., Smyth, J. F. & Langdon, S. P., Dec 2005, In : Endocrine-Related Cancer. 12, 4, p. 851-66 16 p.

    Research output: Contribution to journalArticle

  3. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer

    Macleod, K., Mullen, P., Sewell, J., Rabiasz, G., Lawrie, S., Miller, E., Smyth, J. F. & Langdon, S. P., 1 Aug 2005, In : Cancer Research. 65, 15, p. 6789-800 12 p.

    Research output: Contribution to journalArticle

  4. The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell lines

    Sewell, J. M., Mayer, I., Langdon, S. P., Smyth, J. F., Jodrell, D. I. & Guichard, S. M., Jul 2005, In : European journal of cancer (Oxford, England : 1990). 41, 11, p. 1637-44 8 p.

    Research output: Contribution to journalArticle

  5. WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear

    Gourley, C., Paige, A. J. W., Taylor, K. J., Scott, D., Francis, N-J., Rush, R., Aldaz, C. M., Smyth, J. F. & Gabra, H., Jun 2005, In : International journal of oncology. 26, 6, p. 1681-9 9 p.

    Research output: Contribution to journalArticle

  6. Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration

    Sewell, J. M., Smyth, J. F. & Langdon, S. P., 10 Mar 2005, In : Experimental Cell Research. 304, 1, p. 305-16 12 p.

    Research output: Contribution to journalArticle

  7. 2004
  8. Carcinosarcoma of the ovary: 19 years of prospective data from a single center

    Brown, E., Stewart, M., Rye, T., Al-Nafussi, A., Williams, A. R. W., Bradburn, M., Smyth, J. & Gabra, H., 15 May 2004, In : Cancer. 100, 10, p. 2148-53 6 p.

    Research output: Contribution to journalArticle

  9. Adrenal carcinoma treated with chemotherapy can result in prolonged survival

    Nussey, F., Seckl, J. & Smyth, J., Apr 2004, In : Clinical Oncology. 16, 2, p. 157-158 2 p.

    Research output: Contribution to journalLetter

  10. Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancer

    Mullen, P., McPhillips, F., MacLeod, K., Monia, B., Smyth, J. F. & Langdon, S. P., 15 Mar 2004, In : Clinical Cancer Research. 10, 6, p. 2100-8 9 p.

    Research output: Contribution to journalArticle

  11. 2003
  12. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression

    Stronach, E. A., Sellar, G. C., Blenkiron, C., Rabiasz, G. J., Taylor, K. J., Miller, E. P., Massie, C. E., Al-Nafussi, A., Smyth, J. F., Porteous, D. J. & Gabra, H., 15 Dec 2003, In : Cancer Research. 63, 24, p. 8648-8655 8 p.

    Research output: Contribution to journalArticle

  13. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer

    Sellar, G. C., Watt, K. P., Rabiasz, G. J., Stronach, E. A., Li, L., Miller, E. P., Massie, C. E., Miller, J., Contreras-Moreira, B., Scott, D., Brown, I., Williams, A., Bates, P. A., Smyth, J. F. & Gabra, H., Jul 2003, In : Nature Genetics. 34, 3, p. 337-43 7 p.

    Research output: Contribution to journalArticle